EVERTOGEN LIFE SCIENCES LIMITED
OVERVIEW - EVERTOGEN LIFE SCIENCES LIMITED
Evertogen Life Sciences Limited is an unlisted public company incorporated on 11 January, 2013. It is classified as a public limited company and is located in Hyderabad, Telangana. It's authorized share capital is INR 122.00 cr and the total paid-up capital is INR 119.14 cr.
Evertogen Life Sciences Limited's operating revenues range is INR 1 cr - 100 cr for the financial year ending on 31 March, 2022. It's EBITDA has decreased by -2,274.21 % over the previous year. At the same time, it's book networth has increased by 188.40 %. Other performance and liquidity ratios are available here.
Description: The company undertakes product development, contract development, contract manufacturing, and supply of finished dosages.
Products & Services: Carbidopa/Levodopa IR Tablets, Telmisartan Tablets, LevoCetirizine Di HCL Tablets etc.
Category: Manufacturer
The current status of Evertogen Life Sciences Limited is - Active.
The last reported AGM (Annual General Meeting) of Evertogen Life Sciences Limited, per our records, was held on 08 August, 2023.
Evertogen Life Sciences Limited has six directors - Vikram Ravindra Mamidipudi, Subbarao Kattamuri, and others.
The Corporate Identification Number (CIN) of Evertogen Life Sciences Limited is U24232TG2013PLC085349. The registered office of Evertogen Life Sciences Limited is at 7-2-C8 & C8/2, G V CHAMBERS, SANATH NAGAR IDA, SANATH NAGAR, Hyderabad, Telangana.
REGISTERED DETAILS - EVERTOGEN LIFE SCIENCES LIMITED
CIN
U24232TG2013PLC085349
Incorporation Date / Age
11 January, 2013 / 11 yrs
Last Reported AGM Date
08 August, 2023
Authorized Capital
INR 12200.0 Lacs
Paidup Capital
INR 11913.5613 Lacs
industry*
Manufacturing (Chemicals and chemical products)
type
Unlisted Public Company
category
Company limited by Shares
subcategory
Non-govt company
Registered Address
7-2-C8 & C8/2, G V CHAMBERS, SANATH NAGAR IDA
SANATH NAGAR
Hyderabad - 500018
Telangana - India
FINANCIAL HIGHLIGHTS - EVERTOGEN LIFE SCIENCES LIMITED
| Operating Revenue | INR 1 cr - 100 cr |
| EBITDA | -2,274.21 % |
| Networth | 188.40 % |
| Debt/Equity Ratio | 5.98 |
| Return on Equity | -198.20 % |
* Company has reported to have approved financials for 31 March, 2023. However, in case, they are not available at MCA because of non-filing or damage, then we will provide the latest financials downloadable from MCA.
Directors - EVERTOGEN LIFE SCIENCES LIMITED
The company has 6 directors and no reported key management personnel.
The longest serving directors currently on board are Subbarao Kattamuri and Manav Jassal who were appointed on 11 January, 2013. They have been on the board for more than 11 years. The most recently appointed director is Sherifuddin Sheriff Shaik, who was appointed on 06 December, 2023.
Vikram Ravindra Mamidipudi has the largest number of other directorships with a seat at a total of 25 companies. In total, the company is connected to 38 other companies through its directors.
| NAME | DESIGNATION | APPOINTMENT DATE | |
|---|---|---|---|
| VIKRAM RAVINDRA MAMIDIPUDI | Director | 27 March, 2015 | View other directorships |
| SUBBARAO KATTAMURI | Director | 11 January, 2013 | View other directorships |
| SHERIFUDDIN SHERIFF SHAIK | Director | 06 December, 2023 | View other directorships |
| SUSHMA KATTAMURI | Director | 05 January, 2022 | View other directorships |
| MANAV JASSAL | Director | 11 January, 2013 | View other directorships |
| SAT PAUL JASSAL | Director | 18 June, 2021 | View other directorships |
Previous Names
| OPTIMUS GENERICS LIMITED |
Previous CINs
| No previous CINs were found for this company. |
SIMILAR COMPANIES
| NAME | INCORPORATION YEAR | STATE | PAID UP CAPITAL | |
|---|---|---|---|---|
|
CRONUS PHARMA SPECIALITIES INDIA PRIVATE LIMITED
It was formed in year 2015 in Telangana . The company currently has a paid up capital of INR 119.11 cr.
|
2015 | Telangana | 119.11 cr | Buy financial reports |
|
GLAXOSMITHKLINE CONSUMER PRIVATE LIMITED
It was formed in year 2014 in Punjab . The company currently has a paid up capital of INR 119.73 cr.
|
2014 | Punjab | 119.73 cr | Buy financial reports |
|
2022 ES DISCOVERY INDIA PRIVATE LIMITED
It was formed in year 2022 in Maharashtra . The company currently has a paid up capital of INR 118.50 cr.
|
2022 | Maharashtra | 118.50 cr | Buy financial reports |
|
RESONAC MATERIALS INDIA PRIVATE LIMITED
It was formed in year 2011 in Rajasthan . The company currently has a paid up capital of INR 120.00 cr.
|
2011 | Rajasthan | 120.00 cr | Buy financial reports |
|
INDIAN DRUGS AND PHARMACEUTICALS LIMITED
It was formed in year 1961 in Haryana . The company currently has a paid up capital of INR 116.88 cr.
|
1961 | Haryana | 116.88 cr | Buy financial reports |
|
RELIANCE LIFE SCIENCES PRIVATE LIMITED
It was formed in year 2001 in Maharashtra . The company currently has a paid up capital of INR 115.76 cr.
|
2001 | Maharashtra | 115.76 cr | Buy financial reports |
|
CYZA CHEM PRIVATE LIMITED
It was formed in year 1975 in Maharashtra . The company currently has a paid up capital of INR 115.10 cr.
|
1975 | Maharashtra | 115.10 cr | Buy financial reports |
|
INTAS PHARMACEUTICALS LIMITED
It was formed in year 1985 in Gujarat . The company currently has a paid up capital of INR 114.77 cr.
|
1985 | Gujarat | 114.77 cr | Buy financial reports |
|
TK ELEVATOR INDIA PRIVATE LIMITED
It was formed in year 1999 in Delhi . The company currently has a paid up capital of INR 114.21 cr.
|
1999 | Delhi | 114.21 cr | Buy financial reports |
|
JODAS EXPOIM PRIVATE LIMITED
It was formed in year 2006 in Telangana . The company currently has a paid up capital of INR 113.16 cr.
|
2006 | Telangana | 113.16 cr | Buy financial reports |
SUBSIDIARY COMPANIES
No Indian subsidiary companies found.
Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to their respective owners. Read More